TETRAULT LYNN A. sold RYTM
June 22, 2026 · Form 4 insider transaction
TETRAULT LYNN A. sold 37,000 shares of Rhythm Pharmaceuticals, Inc. at $100.32 per share, a transaction worth $3.71M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on December 15, 2025.; The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $100.00 to $100.91. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.